ClinicalTrials.gov
public full text
Public Domain
The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
To evaluate the effectiveness and safety of Shengmai San in preventing anthracycline sequential trastuzumab therapy related cardiac toxicity through a prospective randomized controlled study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin#1074125
- Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines#887411
- Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects#1008388
- Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer#885191
- Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC#1073265
Record · ID 1095163
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive